Chronic Kidney Disease
VIDEO: Recent developments in anemia care
Healio spoke with Jay B. Wish, MD, about new developments in anemia care.
Whey protein taken with vitamins C, E may reduce CKD inflammation
Whey protein combined with vitamins C and E may significantly reduce inflammation in patients with chronic kidney disease on hemodialysis, according to published data.
Elevated levels of fibroblast growth factor 23 may be linked with heart failure risk
Elevated levels of fibroblast growth factor 23 may be associated with an increased risk for heart failure in adults with chronic kidney disease, according to a recently published study.
TAVR’s renal benefits may outweigh mortality risk for some patients with CKD
In adults with chronic kidney disease and low-flow, low-gradient aortic stenosis, transcatheter aortic valve replacement improved kidney function for more patients than it worsened, data show.
Machine-learning model predicts CKD progression with ‘readily obtainable’ lab data
A machine-learning model developed by researchers at Sonic Healthcare USA accurately predicted the progression of chronic kidney disease using readily available laboratory data.
Women with health issues and CKD face complex challenges
Women who are pregnant and have preeclampsia worry nephrologists like Nityasree Srialluri, MD, MS, because without early detection chronic kidney disease may not be far behind.
Nephrologists need to connect with women’s health issues and CKD
It is critical for nephrologists to provide counseling and treatment when women’s health issues intersect with kidney disease. Much work remains.
New initiative will bring treatment of depression into dialysis units
A new initiative seeks to offer treatment for depression inside the dialysis clinic for patients with both conditions. The program will launch in February of 2024 across four states.
Psychological distress may be linked to poor self-management of chronic kidney disease
Psychological distress may be linked to poor self-management of chronic kidney disease, according to a recently published study of patients with CKD who were not on dialysis.
Canagliflozin mediates biomarkers prognostic of cardiorenal risk in diabetes, albuminuria
Blood tests showed that canagliflozin plus standard care lowered biomarkers levels associated with chronic kidney disease and CVD events in patients with diabetes and albuminuria vs. placebo, researchers reported.